Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients.

BMC Cancer

Department of Medical Oncology Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Dahua Lu, Dongdan, Dongcheng District, Beijing, 100730, China.

Published: March 2025

Purpose: The impact of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) on muscle mass in individuals with advanced lung cancer has yet to be fully delineated. This study aimed to examine the dynamics of skeletal muscle mass during EGFR-TKIs targeted therapy, elucidate its clinical relevance, and explore the potential mechanisms.

Methods: We retrospectively recruited 104 patients with EGFR-mutant advanced lung adenocarcinoma who received icotinib or afatinib as first-line treatment. Skeletal muscle changes were assessed by abdominal CT obtained before and during treatment with EGFR-TKIs. The mean interval (± SD) between two CT scans was 109 days (± 16 days). Targeted panel sequencing of tumor tissue was used to detect genetic alterations. Functional enrichment analysis of genes interacting with EGFR-TKIs and muscle loss was performed to elucidate the potential toxicological mechanisms.

Results: A total of 42 (40.4%) patients experienced muscle loss during targeted therapy. Genetic analysis indicated muscle loss group had a higher proportion of MDM2 amplification and PIK3CA alterations (p = 0.011 & p = 0.045, respectively).Patients with baseline low muscle density and experienced ≥ Grade 2 diarrhea had higher rate of muscle loss (p = 0.005 & p < 0.001, respectively). Multivariate analysis revealed that muscle loss was independently associated with shorter PFS (hazard ratio [HR] 1.86, 95% confidence interval [CI]: 1.09 ∼ 3.18; p = 0.023). Besides, we found genes associated with icotinib, afatinib and muscle loss were significantly enriched in MAPK signaling pathway and calcium signaling pathway.

Conclusions: This study highlights the high prevalence and detrimental impact of muscle loss during EGFR-TKIs treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881361PMC
http://dx.doi.org/10.1186/s12885-025-13775-zDOI Listing

Publication Analysis

Top Keywords

muscle loss
20
skeletal muscle
12
advanced lung
12
muscle
9
lung adenocarcinoma
8
muscle mass
8
targeted therapy
8
loss
5
survival impact
4
impact risk
4

Similar Publications

Periodontitis is one of the major oral health issues worldwide, with significant impacts on oral health and patients's quality of life, but current therapies have not achieved optimal regeneration of periodontal tissue. This study developed scaffolds using natural tussah silk fibroin (TSF) cross-linked with regenerated silk fibroin (SF) nanofibers to improve mechanical properties and wet-state stability. Zinc oxide (ZnO) and polydopamine (PDA) composite nanoparticles were loaded into scaffold to impart its antibacterial and photothermal properties to construct a photo-responsive composite scaffold (ZnO/PDA/TSF-SF).

View Article and Find Full Text PDF

Background: Breast cancer is the second most common cancer in women worldwide. Treatments for this disease often result in side effects such as pain, fatigue, loss of muscle mass, and reduced quality of life. Physical exercise has been shown to effectively mitigate these side effects and improve the quality of life in patients with breast cancer.

View Article and Find Full Text PDF

Context: Sarcopenia is a disease characterized by low muscle mass and function that places individuals at greater risk of disability, loss of independence, and death. Current therapies include addressing underlying performance issues, resistance training, and/or nutritional strategies. However, these approaches have significant limitations, and chronic inflammation associated with sarcopenia may blunt the anabolic response to exercise and nutrition.

View Article and Find Full Text PDF

Objective: To develop and validate the content of a behavioral therapy protocol aiming at improving urinary incontinence in elderly women.

Method: This is a methodological study to develop and validate the content of a protocol to be applied with elderly women with urinary incontinence. It was conducted in two phases: 1) development of the protocol based on a literature review, NANDA-I and NIC; 2) content validation through evaluation of the protocol by experts in a focus group.

View Article and Find Full Text PDF

The detection of cardiac phase in ultrasound videos, identifying end-systolic (ES) and end-diastolic (ED) frames, is a critical step in assessing cardiac function, monitoring structural changes, and diagnosing congenital heart disease. Current popular methods use recurrent neu ral networks to track dependencies over long sequences for cardiac phase detection, but often overlook the short-term motion of cardiac valves that sonographers rely on. In this paper, we propose a novel optical flow-enhanced Mamba U-net framework, designed to utilize both short-term motion and long-term dependencies to detect the cardiac phase in ultrasound videos.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!